IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 244 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $821,000 | -81.8% | 85,655 | -68.4% | 0.01% | -77.3% |
Q1 2022 | $4,516,000 | +9.6% | 271,204 | +25.6% | 0.04% | +18.9% |
Q4 2021 | $4,122,000 | -13.2% | 215,933 | +12.1% | 0.04% | -15.9% |
Q3 2021 | $4,750,000 | +22.2% | 192,629 | +29.0% | 0.04% | +22.2% |
Q2 2021 | $3,887,000 | -14.7% | 149,376 | +3.8% | 0.04% | -20.0% |
Q1 2021 | $4,555,000 | -0.6% | 143,862 | +45.7% | 0.04% | -2.2% |
Q4 2020 | $4,582,000 | +955.8% | 98,747 | +524.0% | 0.05% | +820.0% |
Q2 2020 | $434,000 | -52.5% | 15,825 | -48.1% | 0.01% | -61.5% |
Q1 2020 | $913,000 | -27.0% | 30,504 | -32.5% | 0.01% | -7.1% |
Q4 2019 | $1,251,000 | +338.9% | 45,213 | +189.1% | 0.01% | +366.7% |
Q3 2019 | $285,000 | +75.9% | 15,641 | +137.0% | 0.00% | +50.0% |
Q2 2019 | $162,000 | – | 6,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |